From Neuroplasticity to Symptom Relief: Converging Mechanisms Driving Durable Therapeutic Benefit
- Examining how neuroplastic changes translate into meaningful clinical improvement across depression and related disorders
- Understanding disease related circuit pathology and how targeted therapeutics can repair dysfunctional synapses and circuits
- Comparing neuroplasticity signatures across ketamine, psychedelics, and emerging agents to identify shared mechanistic pathways
- Bridging the gap between molecular plasticity findings and the encoding of lasting therapeutic effects